drugset / Trial / NCT02286258
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
Phase 1/2
Terminated
166 enrolled
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France · collab
Non-randomizedCrossoverOpen-labelDiagnostic
Summary
The purpose of this study is to validate in comparison to a reference method (inuline) two novel non-radioactive biomarkers for glomerular filtration rate (GFR) measurement in chronic-kidney disease (CKD) patients and in healthy volunteers: Calcium-EDTA and Gd-DOTA.
Timeline
- Start
- 2014-10
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edetate Calcium Disodium | Unknown | 10 mg | — |
| Subject | Gadoterate | Diagnostic / imaging agent | 28 ng | — |